Prevalence of ESR1 E380Q mutation in tumor tissue and plasma from Japanese breast cancer patients

ESR1 mutations have attracted attention as a potentially important marker and treatment target in endocrine therapy-resistant breast cancer patients. The E380Q mutation, which is one o...

Source: BMC Cancer - November 22, 2017 Category: Cancer & Oncology Authors: Takashi Takeshita, Yutaka Yamamoto, Mutsuko Yamamoto-Ibusuki, Aiko Sueta, Mai Tomiguchi, Keiichi Murakami, Yoko Omoto and Hirotaka Iwase Tags: Research article Source Type: research